PLR-14

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePLR-14
Drug Alias NameIL-1/TNF alpha synthesis inhibitor (PLIVA)PLR-14
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-1 inhibitors
TargetsInterleukin-1
Therapy Area/IndicationsCrohn DiseaseArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCroatia
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPLIVA dd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPLIVA dd
Active IndicationsN/A
Inactive IndicationsCrohn DiseaseArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A